Common Contracts
10 similar Underwriting Agreement contracts by Catalyst Pharmaceutical Partners, Inc., Aldeyra Therapeutics, Inc., Calithera Biosciences, Inc., others
Calithera Biosciences, Inc. 6,830,000 Shares Common Stock ($0.0001 par value) Underwriting AgreementUnderwriting Agreement • March 22nd, 2017 • Calithera Biosciences, Inc. • Pharmaceutical preparations • New York
Calithera Biosciences, Inc., a corporation organized under the laws of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representative”) are acting as representative, 6,830,000 shares of common stock, $ 0.0001 par value (“Common Stock”) of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to 1,024,500 additional shares of Common Stock (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representative as used herein shall mean you, as Underwriter, and the terms Representative and Underwriters shall mean either the singular or plural as the context requires. Certain terms use
Dermira, Inc. 5,000,000 Shares Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • March 2nd, 2017 • Dermira, Inc. • Pharmaceutical preparations • New York
Dermira, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule II hereto (the “Underwriters”), for whom you (the “Representative”) are acting as representative, the number of shares of common stock, $0.001 par value (“Common Stock”) of the Company set forth on Schedule I hereto (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to the number of additional shares of Common Stock set forth on Schedule I hereto (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule II other than you, the term Representative as used herein shall mean you, as Underwriters, and the term Underwriters shall mean either the singular or
5,181,348 Shares CYMABAY THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 3rd, 2017 • CymaBay Therapeutics, Inc. • Pharmaceutical preparations • New York
Number of Shares] ALDEYRA THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • May 5th, 2015 • Aldeyra Therapeutics, Inc. • Pharmaceutical preparations • New York
3,076,923 Shares TRANSITION THERAPEUTICS INC. Common Shares UNDERWRITING AGREEMENTUnderwriting Agreement • February 12th, 2015 • Transition Therapeutics Inc. • Medicinal chemicals & botanical products • New York
10,000,000 Shares Catalyst Pharmaceutical Partners, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 4th, 2015 • Catalyst Pharmaceutical Partners, Inc. • Pharmaceutical preparations • New York
13,023,750 Shares Catalyst Pharmaceutical Partners, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • April 3rd, 2014 • Catalyst Pharmaceutical Partners, Inc. • Pharmaceutical preparations • New York
6,000,000 Ordinary Shares Compugen Ltd. UNDERWRITING AGREEMENTUnderwriting Agreement • February 28th, 2014 • Compugen LTD • Biological products, (no disgnostic substances) • New York
PARAGON SHIPPING INC. Class A Common Shares, US$0.001 Par Value Per Share and Preferred Share Purchase Rights UNDERWRITING AGREEMENTUnderwriting Agreement • September 19th, 2013 • Paragon Shipping Inc. • Deep sea foreign transportation of freight • New York
1,945,576 Shares CLINICAL DATA, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • June 9th, 2010 • Clinical Data Inc • Pharmaceutical preparations • New York
